Third quarter net sales of $1.824 billion increased 4.0% and 4.
1% on a constant currency 1 basis Third quarter diluted earnings per share were $1.23 ; adjusted 1 diluted earnings per share were $1.74 Company updates 2024 financial guidance, reducing and narrowing range for full year outlook WARSAW, Ind.
, Oct. 30, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2024.
The Company reported third quarter net sales of $1.824 billion , an increase of 4.0% over the prior year period, and an increase of 4.
1% on a constant currency 1 basis. Net earnings for the third quarter were $249.1 million , or $353.
2 million on an adjusted 1 basis. Diluted earnings per share were $1.23 for the third quarter, and adjusted 1 diluted earnings per share were $1.
74 . "We are pleased with the strong performance we delivered in the third quarter, despite our ERP implementation challenges," said Ivan Tornos, Zimmer Biomet's President and Chief Executive Officer. "I am proud of the team and how they came together to manage the ERP issues and mitigate the negative impact on the Company's performance for the year, positioning us to focus on our exciting innovation pipeline and planned new product introductions.
We look forward to delivering on our strategic priorities and advancing our mission to help millions of people alleviate pain and improve their quality of life." Recent Highlights Announced plans for the broa.